1. Home
  2. CRBU vs PCLA Comparison

CRBU vs PCLA Comparison

Compare CRBU & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • PCLA
  • Stock Information
  • Founded
  • CRBU 2011
  • PCLA 2008
  • Country
  • CRBU United States
  • PCLA Japan
  • Employees
  • CRBU N/A
  • PCLA N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • PCLA Building Products
  • Sector
  • CRBU Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • CRBU 151.2M
  • PCLA 175.3M
  • IPO Year
  • CRBU 2021
  • PCLA 2025
  • Fundamental
  • Price
  • CRBU $1.31
  • PCLA $8.60
  • Analyst Decision
  • CRBU Strong Buy
  • PCLA
  • Analyst Count
  • CRBU 5
  • PCLA 0
  • Target Price
  • CRBU $11.80
  • PCLA N/A
  • AVG Volume (30 Days)
  • CRBU 1.3M
  • PCLA 1.5M
  • Earning Date
  • CRBU 03-10-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • CRBU N/A
  • PCLA N/A
  • EPS Growth
  • CRBU N/A
  • PCLA N/A
  • EPS
  • CRBU N/A
  • PCLA N/A
  • Revenue
  • CRBU $11,475,000.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • CRBU N/A
  • PCLA N/A
  • Revenue Next Year
  • CRBU N/A
  • PCLA N/A
  • P/E Ratio
  • CRBU N/A
  • PCLA N/A
  • Revenue Growth
  • CRBU N/A
  • PCLA 40.19
  • 52 Week Low
  • CRBU $1.22
  • PCLA $2.21
  • 52 Week High
  • CRBU $8.33
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 39.05
  • PCLA N/A
  • Support Level
  • CRBU $1.30
  • PCLA N/A
  • Resistance Level
  • CRBU $1.46
  • PCLA N/A
  • Average True Range (ATR)
  • CRBU 0.09
  • PCLA 0.00
  • MACD
  • CRBU 0.02
  • PCLA 0.00
  • Stochastic Oscillator
  • CRBU 33.33
  • PCLA 0.00

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices through distributors and directly to customers. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: